Bicycle Therapeutics Plc - ADR

BCYC

Market Cap$472.54M

Close$

Compare Bicycle Therapeutics Plc

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Bicycle Therapeutics Plc - ADR	-2.8	0%	-47%	21.4	0.1
Market Avg	54.3	1.27%	32%	-	1.3
Healthcare Avg	39.1	1.36%	17%	7.2	1.3

$-24.32

Current Fair Value

213.9% downside

Overvalued by 213.9% based on the discounted cash flow analysis.

Share Statistics

Market cap	$472.54 Million
Enterprise Value	$54.39 Million
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-4.34
Beta	0.93
Outstanding Shares	21,304,801
Avg 30 Day Volume	306,268

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-2.81
PEG	8.78
Price to Sales	21.36
Price to Book Ratio	1.34
Enterprise Value to Revenue	1.31
Enterprise Value to EBIT	-0.3
Enterprise Value to Net Income	-1
Total Debt to Enterprise	0.71
Debt to Equity	0.11

Revenue Sources

No data

ESG Score

No data

About Bicycle Therapeutics Plc

CEO: Kevin Lee